AstaReal Overview
- Year Founded
-
1987
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
AstaReal General Information
Description
Producer of natural astaxanthin in food supplements, cosmetics, beverages, and animal nutrition brands. The company is focused on the extraction of astaxanthin from cultures of a microalgae organism and using it for the production of natural antioxidant formulations in cold-water dispersible powders, oil extracts, and water-soluble emulsion forms, enabling customers to avail a range of products that offer a natural source of astaxanthin which aids to many health benefits.
Contact Information
Website
www.astareal.se(Operating Subsidiary)
Corporate Office
- Forumvägen 14, 16 tr
- 131 53 Nacka
- Sweden
Corporate Office
- Forumvägen 14, 16 tr
- 131 53 Nacka
- Sweden
AstaReal Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Sep-2003 | Completed | Generating Revenue | |||
| 1. Later Stage VC | Completed | Generating Revenue |
AstaReal Comparisons
Industry
Financing
Details
AstaReal Competitors (7)
One of AstaReal’s 7 competitors is Sabinsa, a Corporation company based in East Windsor, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sabinsa | Corporation | East Windsor, NJ | ||||
| Roquette Freres | Private Debt Financed | Lestrem, France | ||||
| SCD Probiotics | Formerly VC-backed | Kansas City, MO | ||||
| Euromed (Consumer Non-Durables) | Formerly PE-Backed | Barcelona, Spain | ||||
| Algatech | Private Equity-Backed | Ketura, Israel |
AstaReal Patents
AstaReal Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3006191-A1 | Method for improving muscle force or physical function | Pending | 21-May-2018 | ||
| US-20020110604-A1 | To inhibit the generation of free radicals and oxidative stress in animal; therapy | Inactive | 11-Aug-2000 | ||
| EP-1267857-B1 | In vitro use of astaxanthin for pretreatment of cells prior to uv-exposure to inhibit the activation of nf-kb | Inactive | 27-Mar-2000 | ||
| DE-60126591-D1 | In vitro use of astaxanthin to pre-treat cells from uv irradiation to inhibit the activation of nf-κb | Inactive | 27-Mar-2000 | ||
| AU-2001242965-A1 | Method of inhibiting the expression of inflammatory cytokines and chemokines | Inactive | 27-Mar-2000 | A61K31/12 |
AstaReal Signals
AstaReal Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HealthCap | Venture Capital | Minority |
AstaReal FAQs
-
When was AstaReal founded?
AstaReal was founded in 1987.
-
Where is AstaReal headquartered?
AstaReal is headquartered in Nacka, Sweden.
-
What is the size of AstaReal?
AstaReal has 20 total employees.
-
What industry is AstaReal in?
AstaReal’s primary industry is Specialty Chemicals.
-
Is AstaReal a private or public company?
AstaReal is a Private company.
-
What is AstaReal’s current revenue?
The current revenue for AstaReal is .
-
Who are AstaReal’s investors?
HealthCap has invested in AstaReal.
-
Who are AstaReal’s competitors?
Sabinsa, Roquette Freres, SCD Probiotics, Euromed (Consumer Non-Durables), and Algatech are some of the 7 competitors of AstaReal.
-
When was AstaReal acquired?
AstaReal was acquired on 01-Sep-2003.
-
Who acquired AstaReal?
AstaReal was acquired by Fuji Chemical Industries.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process